1. Kuller L.H., P. Velentgas, J. Barzilay, N.J. Beauchamp, D.H. O'Leary, P.J. Savage. Diabetes mellitus: subclinical cardiovascular disease and risk of incident cardiovascular disease and all-cause mortality // Arterioscler Thromb Vasc Biol. 2000 Mar; 20(3): p 823-9. 2. Hutchins V., Zhang B, Fleurence RL, Krishnarajah G, Graham J. A systematic review of adherence, treatment satisfaction and costs, in fixed-dose combination regimens in type 2 diabetes. Curr Med Res Opin. 2011 Jun;27(6):1157-68. 3. Punthakee Z., Goldenberg R, Katz P (2018) Definition, classification and diagnosis of diabetes, prediabetes and metabolic syndrome. Can J Diabetes 42:S10–S15 4. Reid G., Jass J., Sebulsky MT, McCormick JK. Potential uses of probiotics in clinical practice. Clin Microbiol Rev. 2003;16(4):658–72. 5. Ismaeel A.Y., Botta GA. Probiotics: facts and myths. Clin Microbiol Infect. 2005;11(12):958–66. 6. Bekmurodova G.A., Amirsaidova D. I, Miralimova Sh. M., and Imamaliev B. A. The Hypoglycemic Activity of Lactic Acid Bacteria Isolated From Medicinal Plants Of Uzbekistan And Their Probiotic Potential // Jurnal of Pharmaceutecal research international 33(60B): 445-457, 22 december 2021; Article no.JPRI. 79979 7. Clarke T.C., Black LI, Stussman B.J., Barnes P.M., Nahin RL. Trends in the use of complementary health approaches among adults: United States, 2002–2012. Natl Health Stat Report. 2015(79):1–16 8. Tabrizi R., Moosazadeh M, Lankarani K.B., Akbari M., Heydari S.T., Kolahdooz F., Asemi Z (2018) The effects of synbiotic supplementation on glucose metabolism and lipid profiles in patients with diabetes: a systematic review and meta-analysis of randomized controlled trials. Probiotics Antimicro 10:329–342 9. Машковский М.Д. Лекарственные средства: В 2 т. – 14-е изд., перераб., испр. и доп. – М.: ООО «Издательство Новая Волна»: Издатель С.Б. Дивов, 2002. – 1148 с. 10. Миронова А.Н. Руководство по проведению доклинических исследований лекарственных средств. Часть первая М.: Гриф и К, 2012. – 944 с. 11. Стефанова А.В. Доклинические исследования лекарственных средств (методические рекомендaция). – Киев: Авицена, 2002. – 568 с. 12. Honda K. et al. Anti-diabetic eффects oф lactic acid bacteria in normal and type 2 diabetic mice J Clin Biochem Nutr 2012. p- p-10041-59. 13. Kocsis T. et al. Probiotics have beneфicial metabolic eффects in patients with type 2 diabetes mellitus: a meta-analysis oф randomized clinical trials Sci Rep 2020. P-12148-65 14. Yadav H., Jain S, Sinha PR (2007) Antidiabetic effect of probiotic dahi containing Lactobacillus acidophilus and Lactobacillus casei in high fructose fed rats. Nutrition 23(1):62–68 15. Bejar W., Hamden K, Ben Salah R, Chouayekh H (2013) Lactobacillus plantarum TN627 significantly reduces complications of alloxan-induced diabetes in rats. Anaerobe 24:4–11 16. Chen P, Zhang Q, Dang H et al (2014) Antidiabetic effect of Lactobacillus casei CCFM0412 on mice with type 2 diabetes induced by a high-fat diet and streptozotocin. Nutrition 30(9):1061–1068 17. Бекмуродова Г.А. Амирсаидова Д. А., Выпова Н.Л., Миралимова Ш. М. Гипогликемический потенциал пробиотических бактерий // Международная дистанционная научно-практическая конференция “Integration into the world and connection of sciences”, Боку, Азарбайжан. 2020., октябр. р.53 18. Gjedsted J., M. Buhl, S. Nielsen, O. Schmitz, E. T. Vestergaard, E. Tønnesen, N. Møller/ Effects of adrenaline on lactate, glucose, lipid and protein metabolism in the placebo controlled bilaterally perfused human leg// J Acta Physiologica 202- jild , 4- son, 2011 yil avgust, 641-648 19. Osasenaga M. I., Abiola Mohammed Adeosun, Oluseyi Adeboye Akinloye, Alloxan-induced diabetes, a common model for evaluating the glycemic-control potential of therapeutic compounds and plants extracts in experimental studies, Medicina, Volume 53, Issue 6, 2017, Pages 365-374 20. Galland L. The gut microbiome and the brain. J Med Food. 2014 Dec;17(12):1261-72